buserelin has been researched along with desogestrel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anserini, P; Capitanio, GL; Gaggero, G; Magnasco, A; Remorgida, V; Testa, D | 1 |
| Biljan, MM; Bissonnette, F; Dean, N; Hemmings, R; Mahutte, NG; Tan, SL | 1 |
2 other study(ies) available for buserelin and desogestrel
| Article | Year |
|---|---|
Comparison of a blocking vs. a flare-up protocol in poor responders with a normal and abnormal clomiphene citrate challenge test.
Topics: Adult; Buserelin; Chorionic Gonadotropin; Clomiphene; Desogestrel; Embryo Transfer; Estradiol; Ethinyl Estradiol; Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gamete Intrafallopian Transfer; Humans; Infertility; Menotropins; Ovulation Induction; Pregnancy; Triptorelin Pamoate | 1997 |
Pretreatment with an oral contraceptive is effective in reducing the incidence of functional ovarian cyst formation during pituitary suppression by gonadotropin-releasing hormone analogues.
Topics: Adult; Buserelin; Case-Control Studies; Desogestrel; Estradiol Congeners; Ethinyl Estradiol; Female; Fertility Agents, Female; Fertilization in Vitro; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Menotropins; Ovarian Cysts; Ovarian Follicle; Ovulation Induction; Pituitary Gland, Anterior; Pregnancy; Pregnancy Rate; Premedication; Progesterone Congeners; Retrospective Studies; Secretory Rate | 1998 |